PMC:3359311 / 236-347 JSONTXT

{"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T364","span":{"begin":52,"end":70},"obj":"P01584"},{"id":"T365","span":{"begin":72,"end":77},"obj":"P01584"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":"and outcome for patients with cystic fibrosis (CF). Interleukin-1 beta (IL-1β) is a key inflammatory mediator. "}

{"project":"bionlp-st-ge-2016-reference","denotations":[{"id":"T40","span":{"begin":52,"end":70},"obj":"Protein"},{"id":"T41","span":{"begin":72,"end":77},"obj":"Protein"}],"relations":[{"id":"R25","pred":"equivalentTo","subj":"T41","obj":"T40"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":"and outcome for patients with cystic fibrosis (CF). Interleukin-1 beta (IL-1β) is a key inflammatory mediator. "}

{"project":"bionlp-st-ge-2016-reference-tees","denotations":[{"id":"T802","span":{"begin":52,"end":70},"obj":"Protein"},{"id":"T803","span":{"begin":72,"end":77},"obj":"Protein"},{"id":"T804","span":{"begin":101,"end":109},"obj":"Positive_regulation"},{"id":"T805","span":{"begin":101,"end":109},"obj":"Positive_regulation"}],"relations":[{"id":"R667","pred":"themeOf","subj":"T802","obj":"T804"},{"id":"R668","pred":"themeOf","subj":"T803","obj":"T805"}],"text":"and outcome for patients with cystic fibrosis (CF). Interleukin-1 beta (IL-1β) is a key inflammatory mediator. "}

{"project":"events-check-again","denotations":[{"id":"T770","span":{"begin":52,"end":70},"obj":"Protein"},{"id":"T771","span":{"begin":72,"end":77},"obj":"Protein"}],"relations":[{"id":"R647","pred":"equivalentTo","subj":"T771","obj":"T770"}],"text":"and outcome for patients with cystic fibrosis (CF). Interleukin-1 beta (IL-1β) is a key inflammatory mediator. "}

{"project":"ICD10","denotations":[{"id":"T694","span":{"begin":30,"end":45},"obj":"http://purl.bioontology.org/ontology/ICD10/E84"},{"id":"T695","span":{"begin":30,"end":45},"obj":"http://purl.bioontology.org/ontology/ICD10/E84.9"}],"text":"and outcome for patients with cystic fibrosis (CF). Interleukin-1 beta (IL-1β) is a key inflammatory mediator. "}

{"project":"GO-BP","denotations":[{"id":"T681","span":{"begin":52,"end":70},"obj":"http://purl.obolibrary.org/obo/GO_0050720"},{"id":"T682","span":{"begin":52,"end":70},"obj":"http://purl.obolibrary.org/obo/GO_0050702"},{"id":"T683","span":{"begin":64,"end":74},"obj":"http://purl.obolibrary.org/obo/GO_0032611"}],"text":"and outcome for patients with cystic fibrosis (CF). Interleukin-1 beta (IL-1β) is a key inflammatory mediator. "}

{"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T403","span":{"begin":0,"end":3},"obj":"CC"},{"id":"T404","span":{"begin":4,"end":11},"obj":"NN"},{"id":"T405","span":{"begin":12,"end":15},"obj":"IN"},{"id":"T406","span":{"begin":16,"end":24},"obj":"NNS"},{"id":"T407","span":{"begin":25,"end":29},"obj":"IN"},{"id":"T408","span":{"begin":30,"end":36},"obj":"JJ"},{"id":"T409","span":{"begin":37,"end":45},"obj":"NN"},{"id":"T410","span":{"begin":46,"end":47},"obj":"-LRB-"},{"id":"T411","span":{"begin":47,"end":49},"obj":"NNP"},{"id":"T412","span":{"begin":49,"end":50},"obj":"-RRB-"},{"id":"T413","span":{"begin":50,"end":51},"obj":"."},{"id":"T414","span":{"begin":52,"end":65},"obj":"NN"},{"id":"T415","span":{"begin":66,"end":70},"obj":"NN"},{"id":"T416","span":{"begin":71,"end":72},"obj":"-LRB-"},{"id":"T417","span":{"begin":72,"end":77},"obj":"NN"},{"id":"T418","span":{"begin":77,"end":78},"obj":"-RRB-"},{"id":"T419","span":{"begin":79,"end":81},"obj":"VBZ"},{"id":"T420","span":{"begin":82,"end":83},"obj":"DT"},{"id":"T421","span":{"begin":84,"end":87},"obj":"JJ"},{"id":"T422","span":{"begin":88,"end":100},"obj":"JJ"},{"id":"T423","span":{"begin":101,"end":109},"obj":"NN"},{"id":"T424","span":{"begin":109,"end":110},"obj":"."}],"relations":[{"id":"R344","pred":"pobj","subj":"T406","obj":"T405"},{"id":"R345","pred":"prep","subj":"T407","obj":"T406"},{"id":"R346","pred":"compound","subj":"T408","obj":"T409"},{"id":"R347","pred":"pobj","subj":"T409","obj":"T407"},{"id":"R348","pred":"punct","subj":"T410","obj":"T411"},{"id":"R349","pred":"appos","subj":"T411","obj":"T409"},{"id":"R352","pred":"compound","subj":"T414","obj":"T415"},{"id":"R353","pred":"nsubj","subj":"T415","obj":"T419"},{"id":"R354","pred":"punct","subj":"T416","obj":"T417"},{"id":"R355","pred":"appos","subj":"T417","obj":"T415"},{"id":"R356","pred":"punct","subj":"T418","obj":"T417"},{"id":"R357","pred":"ROOT","subj":"T419","obj":"T419"},{"id":"R358","pred":"det","subj":"T420","obj":"T423"},{"id":"R359","pred":"amod","subj":"T421","obj":"T423"},{"id":"R360","pred":"amod","subj":"T422","obj":"T423"},{"id":"R361","pred":"attr","subj":"T423","obj":"T419"},{"id":"R362","pred":"punct","subj":"T424","obj":"T419"}],"text":"and outcome for patients with cystic fibrosis (CF). Interleukin-1 beta (IL-1β) is a key inflammatory mediator. "}

{"project":"pmc-enju-pas","denotations":[{"id":"T114","span":{"begin":0,"end":3},"obj":"CC"},{"id":"T115","span":{"begin":4,"end":11},"obj":"NN"},{"id":"T116","span":{"begin":12,"end":15},"obj":"IN"},{"id":"T117","span":{"begin":16,"end":24},"obj":"NN"},{"id":"T118","span":{"begin":25,"end":29},"obj":"IN"},{"id":"T119","span":{"begin":30,"end":36},"obj":"JJ"},{"id":"T120","span":{"begin":37,"end":45},"obj":"NN"},{"id":"T121","span":{"begin":46,"end":47},"obj":"-LRB-"},{"id":"T122","span":{"begin":47,"end":49},"obj":"NN"},{"id":"T123","span":{"begin":49,"end":50},"obj":"-RRB-"},{"id":"T124","span":{"begin":52,"end":65},"obj":"NN"},{"id":"T125","span":{"begin":66,"end":70},"obj":"NN"},{"id":"T126","span":{"begin":71,"end":72},"obj":"-LRB-"},{"id":"T127","span":{"begin":72,"end":77},"obj":"NN"},{"id":"T128","span":{"begin":77,"end":78},"obj":"-RRB-"},{"id":"T129","span":{"begin":79,"end":81},"obj":"VB"},{"id":"T130","span":{"begin":82,"end":83},"obj":"DT"},{"id":"T131","span":{"begin":84,"end":87},"obj":"JJ"},{"id":"T132","span":{"begin":88,"end":100},"obj":"JJ"},{"id":"T133","span":{"begin":101,"end":109},"obj":"NN"}],"relations":[{"id":"R70","pred":"arg2Of","subj":"T115","obj":"T114"},{"id":"R71","pred":"arg2Of","subj":"T117","obj":"T116"},{"id":"R72","pred":"arg1Of","subj":"T117","obj":"T118"},{"id":"R73","pred":"arg2Of","subj":"T120","obj":"T118"},{"id":"R74","pred":"arg1Of","subj":"T120","obj":"T119"},{"id":"R75","pred":"arg1Of","subj":"T120","obj":"T121"},{"id":"R76","pred":"arg2Of","subj":"T122","obj":"T121"},{"id":"R77","pred":"arg3Of","subj":"T123","obj":"T121"},{"id":"R78","pred":"arg1Of","subj":"T125","obj":"T124"},{"id":"R79","pred":"arg1Of","subj":"T125","obj":"T126"},{"id":"R80","pred":"arg1Of","subj":"T125","obj":"T129"},{"id":"R81","pred":"arg2Of","subj":"T127","obj":"T126"},{"id":"R82","pred":"arg3Of","subj":"T128","obj":"T126"},{"id":"R83","pred":"arg2Of","subj":"T133","obj":"T129"},{"id":"R84","pred":"arg1Of","subj":"T133","obj":"T130"},{"id":"R85","pred":"arg1Of","subj":"T133","obj":"T131"},{"id":"R86","pred":"arg1Of","subj":"T133","obj":"T132"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"and outcome for patients with cystic fibrosis (CF). Interleukin-1 beta (IL-1β) is a key inflammatory mediator. "}

{"project":"sentences","denotations":[{"id":"T75","span":{"begin":52,"end":110},"obj":"Sentence"},{"id":"T5","span":{"begin":52,"end":110},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"and outcome for patients with cystic fibrosis (CF). Interleukin-1 beta (IL-1β) is a key inflammatory mediator. "}